AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.890
+0.160 (5.86%)
At close: Nov 4, 2024, 4:00 PM
2.730
-0.160 (-5.54%)
Pre-market: Nov 5, 2024, 9:25 AM EST
AbCellera Biologics Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$11.00
Upside
+280.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 20, 2024 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +73.01% | Jul 11, 2024 |
| Keybanc | Keybanc | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +142.21% | May 8, 2024 |
| Benchmark | Benchmark | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 22, 2024 |
| Stifel | Stifel | Strong Buy Maintains $21 → $17 | Strong Buy | Maintains | $21 → $17 | +488.24% | Feb 21, 2024 |
| Keybanc | Keybanc | Buy Initiates $6 | Buy | Initiates | $6 | +107.61% | Dec 5, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $20 | Buy | Initiates | $20 | +592.04% | Oct 13, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $20 → $12 | Strong Buy | Maintains | $20 → $12 | +315.22% | Aug 31, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $27 → $24 | Strong Buy | Maintains | $27 → $24 | +730.45% | Aug 4, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $34 → $28 | Buy | Maintains | $34 → $28 | +868.86% | May 5, 2023 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2023 |
| BMO Capital | BMO Capital | Buy Maintains $40 → $32 | Buy | Maintains | $40 → $32 | +1,007.27% | Feb 22, 2023 |
| Credit Suisse | Credit Suisse | Buy Reiterates $34 | Buy | Reiterates | $34 | +1,076.47% | Feb 22, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $20 → $18 | Buy | Maintains | $20 → $18 | +522.84% | Jan 6, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +938.06% | Dec 15, 2022 |
| Truist Securities | Truist Securities | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +903.46% | Nov 16, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.